Unrestricted metabolic research grant awarded to Beth Israel Deaconess
PRINCETON, NJ -- Bristol-Myers Squibb has awarded a five-year $500,000 Unrestricted Metabolic Research Grant to Beth Israel Deaconess Medical Center in Boston for research investigating the mechanisms of insulin action and resistance, the molecular and cellular aspects of obesity, and the relationship of obesity to type II diabetes. ...Jeffrey S. Flier, M.D., whose research in diabetes and obesit...Joslin and Beth Israel Deaconess Medical Center sign new joint venture clinical agreement
BOSTON Joslin Diabetes Center and Beth Israel Deaconess Medical Center (BIDMC) have signed a five-year agreement that expands and improves the longstanding clinical collaboration between these two institutions to provide preeminent specialty care for people with diabetes.... ...Joslin Clinic brings to the joint venture expertise in caring for and educating people with diabetes and their familie...Beth Israel Deaconess Medical Center and Alveolus, Inc., announce agreement
BOSTON -- Beth Israel Deaconess Medical Center (BIDMC) and Alveolus, Inc., have announced the establishment of a program to pursue research and physician education in the field of interventional pulmonology. Based at BIDMC, the program will be headed by Armin Ernst, MD, Director of Interventional Pulmonology and Critical Care Medicine and a nationally renowned expert on central airway obstruction...Beth Israel Deaconess study documents outstanding surgical outcomes for diabetes patients
BOSTON Contrary to the long-held belief that surgery poses a significant danger to patients with diabetes mellitus, a 10-year study of more than 6,500 patients from Beth Israel Deaconess Medical Center (BIDMC) has shown a mortality rate of only 1 percent among diabetes patients undergoing major vascular operations.... The findings, published in the April issue of the Archives of Surgery and pre....BOSTON -- William Cohn, M.D., a cardiothoracic surgeon at Beth Israel Deaconess Medical Center, will receive the 2000 Distinguished Inventor Award from the Intellectual Property Owners Association (IPO). Cohn is being honored for inventing the Cohn Cardiac Stabilizer, a device and method that makes it possible to perform coronary artery bypass surgery on a beating heart without the use of a hea...